Abstract

Clinical Outcomes in ALLHAT Antihypertensive Trial Participants with Type 2 Diabetes, Impaired Fasting Glucose, and Normoglycemia.

Authors: Paul K. Whelton MD, Joshua Barzilay MD, William C. Cushman MD, Barry R. Davis MD, PhD, Ekambaram Iiamathi MD, John B. Kostis MD, Frans H.H. Leenen MD, Gail T. Louis RN, Karen Margolis MD, David E. Mathis MD, Jamal Moloo MD, Chuke Nwachuku MA, MPH, Deborah Panebianco MD, David C. Parish MD, Sara Pressel MS, Debra L. Simmons MD, Udho Thadani MD

Abstract

Annual Supplement of Abstracts: Southern Medical Association's 98th Annual Scientific Assembly: Oral Presentation Abstracts: Abstracts of Scientific Papers: Section on Cardiology

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

Annual Supplement of Abstracts: Southern Medical Association's 98th Annual Scientific Assembly: Oral Presentation Abstracts: Abstracts of Scientific Papers: Section on Cardiology